These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 37485661)

  • 1. Indoleamine 2,3-Dioxygenase 1 Deletion-Mediated Kynurenine Insufficiency Inhibits Pathological Cardiac Hypertrophy.
    Wang Y; Song J; Yu K; Nie D; Zhao C; Jiao L; Wang Z; Zhou L; Wang F; Yu Q; Zhang S; Wen Z; Wu J; Wang CY; Wang DW; Cheng J; Zhao C
    Hypertension; 2023 Oct; 80(10):2099-2111. PubMed ID: 37485661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indoleamine 2,3-Dioxygenase 1 (IDO1) Promotes Cardiac Hypertrophy via a PI3K-AKT-mTOR-Dependent Mechanism.
    Liu Y; Li S; Gao Z; Li S; Tan Q; Li Y; Wang D; Wang Q
    Cardiovasc Toxicol; 2021 Aug; 21(8):655-668. PubMed ID: 34021461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia
    Atene CG; Fiorcari S; Mesini N; Alboni S; Martinelli S; Maccaferri M; Leonardi G; Potenza L; Luppi M; Maffei R; Marasca R
    Front Immunol; 2022; 13():832263. PubMed ID: 35371054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indoleamine 2,3-Dioxygenase 1 Deletion-Mediated Kynurenine Insufficiency in Vascular Smooth Muscle Cells Exacerbates Arterial Calcification.
    Ouyang L; Yu C; Xie Z; Su X; Xu Z; Song P; Li J; Huang H; Ding Y; Zou MH
    Circulation; 2022 Jun; 145(24):1784-1798. PubMed ID: 35582948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn-AhR-AQP4 signaling pathway.
    Du L; Xing Z; Tao B; Li T; Yang D; Li W; Zheng Y; Kuang C; Yang Q
    Signal Transduct Target Ther; 2020 Feb; 5(1):10. PubMed ID: 32296044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kynurenine produced by indoleamine 2,3-dioxygenase 2 exacerbates acute liver injury by carbon tetrachloride in mice.
    Hoshi M; Osawa Y; Nakamoto K; Morita N; Yamamoto Y; Ando T; Tashita C; Nabeshima T; Saito K
    Toxicology; 2020 May; 438():152458. PubMed ID: 32289347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of indoleamine-2,3-dioxygenase 1, tryptophan-2,3-dioxygenase, and Ido1/Tdo2 knockout mice.
    Aslamkhan AG; Xu Q; Loughlin A; Vu H; Pacchione S; Bhatt B; Garfinkel I; Styring TG; LaFranco-Scheuch L; Pearson K; Reynolds S; Li N; Zhou H; Miller JR; Solban N; Bass A; Glaab WE
    Toxicol Appl Pharmacol; 2020 Nov; 406():115216. PubMed ID: 32871117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of indoleamine 2,3-dioxygenase 1 (IDO1) and kynurenine pathway in the regulation of the aging process.
    Salminen A
    Ageing Res Rev; 2022 Mar; 75():101573. PubMed ID: 35085834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan-Kynurenine-Aryl Hydrocarbon Axis.
    Labadie BW; Bao R; Luke JJ
    Clin Cancer Res; 2019 Mar; 25(5):1462-1471. PubMed ID: 30377198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation.
    Mondanelli G; Coletti A; Greco FA; Pallotta MT; Orabona C; Iacono A; Belladonna ML; Albini E; Panfili E; Fallarino F; Gargaro M; Manni G; Matino D; Carvalho A; Cunha C; Maciel P; Di Filippo M; Gaetani L; Bianchi R; Vacca C; Iamandii IM; Proietti E; Boscia F; Annunziato L; Peppelenbosch M; Puccetti P; Calabresi P; Macchiarulo A; Santambrogio L; Volpi C; Grohmann U
    Proc Natl Acad Sci U S A; 2020 Feb; 117(7):3848-3857. PubMed ID: 32024760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kynurenine promotes neonatal heart regeneration by stimulating cardiomyocyte proliferation and cardiac angiogenesis.
    Zhang D; Ning J; Ramprasath T; Yu C; Zheng X; Song P; Xie Z; Zou MH
    Nat Commun; 2022 Oct; 13(1):6371. PubMed ID: 36289221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced tryptophan-kynurenine metabolism via indoleamine 2,3-dioxygenase 1 induction in dermatomyositis.
    Wu D; Chen M; Chen S; Zhang S; Chen Y; Zhao Q; Xue K; Xue F; Chen X; Zhou M; Li H; Zheng J; Le Y; Cao H
    Clin Rheumatol; 2022 Oct; 41(10):3107-3117. PubMed ID: 35778590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities.
    Cheong JE; Sun L
    Trends Pharmacol Sci; 2018 Mar; 39(3):307-325. PubMed ID: 29254698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs.
    Volarevic V; Markovic BS; Jankovic MG; Djokovic B; Jovicic N; Harrell CR; Fellabaum C; Djonov V; Arsenijevic N; Lukic ML
    Theranostics; 2019; 9(20):5976-6001. PubMed ID: 31534532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tryptophan depletion sensitizes the AHR pathway by increasing AHR expression and GCN2/LAT1-mediated kynurenine uptake, and potentiates induction of regulatory T lymphocytes.
    Solvay M; Holfelder P; Klaessens S; Pilotte L; Stroobant V; Lamy J; Naulaerts S; Spillier Q; Frédérick R; De Plaen E; Sers C; Opitz CA; Van den Eynde BJ; Zhu J
    J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37344101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IDO1/TDO dual inhibitor RY103 targets Kyn-AhR pathway and exhibits preclinical efficacy on pancreatic cancer.
    Liang H; Li T; Fang X; Xing Z; Zhang S; Shi L; Li W; Guo L; Kuang C; Liu H; Yang Q
    Cancer Lett; 2021 Dec; 522():32-43. PubMed ID: 34520819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipocyte-derived kynurenine promotes obesity and insulin resistance by activating the AhR/STAT3/IL-6 signaling.
    Huang T; Song J; Gao J; Cheng J; Xie H; Zhang L; Wang YH; Gao Z; Wang Y; Wang X; He J; Liu S; Yu Q; Zhang S; Xiong F; Zhou Q; Wang CY
    Nat Commun; 2022 Jun; 13(1):3489. PubMed ID: 35715443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenetic Interplay Between IL-6 and Tryptophan Metabolism in an Experimental Model of Obesity.
    Mondanelli G; Albini E; Orecchini E; Pallotta MT; Belladonna ML; Ricci G; Grohmann U; Orabona C
    Front Immunol; 2021; 12():713989. PubMed ID: 34394118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-γ induces a tryptophan-selective amino acid transporter in human colonic epithelial cells and mouse dendritic cells.
    Bhutia YD; Babu E; Ganapathy V
    Biochim Biophys Acta; 2015 Feb; 1848(2):453-62. PubMed ID: 25450809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IDO1 promotes CSFV replication by mediating tryptophan metabolism to inhibit NF-κB signaling.
    Zhao F; Huang Y; Ji J; Liu X; Li X; Zou L; Wu K; Liu Xd; Zeng S; Wang X; Hu W; Song Y; Lu Z; Zhou B; Li P; Wang W; Zhao M; Chen J; Yi L; Fan S
    J Virol; 2024 Jul; 98(7):e0045824. PubMed ID: 38814067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.